Long‐term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14‐year, single‐center experience

The long‐term effects of tyrosine kinase inhibitors (TKIs), including imatinib, and surgical intervention on advanced gastrointestinal stromal tumor (GIST) were evaluated. All 379 patients had metastatic or recurrent GIST and started 400 mg/d imatinib at the Asan Medical Center in periods 1 and 2 [2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Kim, Jwa Hoon, Ryu, Min‐Hee, Yoo, Changhoon, Chae, Heejung, Na, Hana, Beck, Moyoul, Kim, Beom Su, Yoo, Moon‐Won, Yook, Jeong Hwan, Kim, Byung Sik, Kim, Ki‐Hun, Kim, Chan Wook, Kang, Yoon‐Koo
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6434201/
https://ncbi.nlm.nih.gov/pubmed/30693663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1994
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados